middle.news

Anteris finds encouraging DurAVR performance in challenging small-annulus patients

9:03am on Monday 23rd of November, 2026 AEDT • Healthcare
Read Story

Anteris finds encouraging DurAVR performance in challenging small-annulus patients

9:03am on Monday 23rd of November, 2026 AEDT
Key Points
  • 1% heart failure hospitalisation at one year
  • 8.9 mmHg mean pressure gradient and 2.2 cm² mean effective orifice area
  • No moderate or severe paravalvular leak or valve-related deaths reported
  • 96% of patients in NYHA class I/II at one year
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Anteris Technologies Global (ASX:AVR)
OPEN ARTICLE